These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22671427)

  • 21. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
    Toussaint ND; Lau KK; Strauss BJ; Polkinghorne KR; Kerr PG
    Nephrol Dial Transplant; 2008 Feb; 23(2):586-93. PubMed ID: 17933842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure.
    Cottone S; Lorito MC; Riccobene R; Nardi E; Mulè G; Buscemi S; Geraci C; Guarneri M; Arsena R; Cerasola G
    J Nephrol; 2008; 21(2):175-9. PubMed ID: 18446711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vascular damage in chronic kidney disease].
    Jara A; Mezzano S
    Rev Med Chil; 2008 Nov; 136(11):1476-84. PubMed ID: 19301781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney disease.
    Ueda S; Yamagishi S; Kaida Y; Okuda S
    Nephrology (Carlton); 2007 Dec; 12(6):582-90. PubMed ID: 17995585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experimental study of the mechanism for vascular calcification in chronic kidney disease].
    Persy V
    Verh K Acad Geneeskd Belg; 2008; 70(4):285-303. PubMed ID: 19166100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiological mechanisms and consequences of cardiovascular calcifications: role of uremic toxicity.
    Chillon JM; Mozar A; Six I; Maizel J; Bugnicourt JM; Kamel S; Slama M; Brazier M; Massy ZA
    Ann Pharm Fr; 2009 Jul; 67(4):234-40. PubMed ID: 19596096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular effects of uremia in apolipoprotein E-deficient mice.
    Bro S
    Dan Med Bull; 2009 Nov; 56(4):177-92. PubMed ID: 19939336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The renal patient with cardiovascular disease--no longer a simple plumbing problem.
    Tunuguntla A; Yerra L
    Tenn Med; 2005 Aug; 98(8):395-6, 399. PubMed ID: 16315466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arterial stiffness and pulse pressure in CKD and ESRD.
    Briet M; Boutouyrie P; Laurent S; London GM
    Kidney Int; 2012 Aug; 82(4):388-400. PubMed ID: 22534962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular disease and atherosclerosis in uremia.
    London GM
    Nefrologia; 2005; 25 Suppl 2():91-5. PubMed ID: 16050410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphate metabolism in the setting of chronic kidney disease: significance and recommendations for treatment.
    Kestenbaum B
    Semin Dial; 2007; 20(4):286-94. PubMed ID: 17635817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arterial calcification in patients with chronic kidney disease.
    Koleganova N; Piecha G; Ritz E; Schirmacher P; Müller A; Meyer HP; Gross ML
    Nephrol Dial Transplant; 2009 Aug; 24(8):2488-96. PubMed ID: 19329792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soft bone - hard arteries: a link?
    London GM
    Kidney Blood Press Res; 2011; 34(4):203-8. PubMed ID: 21691122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue.
    Toussaint ND; Elder GJ; Kerr PG
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):221-33. PubMed ID: 18987295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular calcification in chronic kidney disease: a clinical review.
    Eddington H; Sinha S; Kalra PA
    J Ren Care; 2009 Mar; 35 Suppl 1():45-50. PubMed ID: 19222731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation.
    Schepers E; Glorieux G; Dou L; Cerini C; Gayrard N; Louvet L; Maugard C; Preus P; Rodriguez-Ortiz M; Argiles A; Brunet P; Cohen G; Jankowski J; Jankowski V; Massy Z; Rodriguez M; Vanholder R;
    Blood Purif; 2010; 30(4):277-87. PubMed ID: 21079396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease?
    Peiskerová M; Kalousová M; Kratochvílová M; Dusilová-Sulková S; Uhrová J; Bandúr S; Malbohan IM; Zima T; Tesar V
    Kidney Blood Press Res; 2009; 32(4):276-83. PubMed ID: 19797911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular calcification in chronic kidney disease.
    Covic A; Kanbay M; Voroneanu L; Turgut F; Serban DN; Serban IL; Goldsmith DJ
    Clin Sci (Lond); 2010 Apr; 119(3):111-21. PubMed ID: 20443781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiovascular system in patients in different stages of chronic kidney disease].
    Strózecki P; Kozłowski M; Grajewska M; Kurowski R; Stefańska A; Odrowaź-Sypniewska G; Serafin Z; Lasek W; Nartowicz E; Kubica J; Manitius J
    Pol Merkur Lekarski; 2006 Aug; 21(122):125-9; discussion 130-1. PubMed ID: 17144094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular risk and mineral bone disorder in patients with chronic kidney disease.
    Staude H; Jeske S; Schmitz K; Warncke G; Fischer DC
    Kidney Blood Press Res; 2013; 37(1):68-83. PubMed ID: 23548827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.